JPRN-UMIN000011896已完成未知
Efficacy and safety of minodronate in the treatment of glucocorticoid-induced osteoporosis - Effect of minodronate in glucocorticoid-induced osteoporosis
Department of Medicine, School of Medicine, Nihon University0 个研究点目标入组 30 人开始时间: 2013年9月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patients with peptic ulcers (2) Patients with esophageal stricture or achalasia (3) Patients unable to remain upright for 30 min after dosing 4) Patients with hypocalcaemia (5) Patients who received any prior bisphosphonate less than six months before entry (6) Females with pregnancy and lactating
研究者
相似试验
已完成
不适用
Efficacy of monthly minodronate for the treatment of osteoporosis associated with rheumatoid arthritis after previous treatment with bisphosphonatesOsteoporosisJPRN-UMIN000011087Osaka University Graduate School of Medicine100
招募中
不适用
Comparative study of efficacy of minodronate, alendronate and risedronate in patients with osteoporosisOsteoporosisJPRN-UMIN000011407Kushiro-sanjikai Hospital150
已完成
2 期
Treatment of thalassemia-induced osteoporosis with pamidronateThalassemia.Beta thalassemiaD56.1IRCT20211008052698N1Oroumia University of Medical Sciences20
进行中（未招募）
不适用
Mildronate - Efficacy And Safety Of Treatment For Chronic Coronary Heart Disease (Stable Angina) I - MILSS IEUCTR2007-005179-32-LVJoint Stock Company Grindeks
尚未招募
4 期
Efficacy and Safety of Minodronate in Patients With Low Back PainPostmenopausal OsteoporosisNCT05645289Peking University Third Hospital72